GlassScriptPhysician profile
Gloria C Hui
NPI 1821030438
$45,786.89
in general payments reported to CMS, 2019-2025
53 companies · $3,765 in 2025
The $3,765 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $2,870 · 2021: $3,455 · 2022: $7,946 · 2023: $5,805 · 2024: $3,823 · 2025: $3,765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $1,663 · Education: $84.99 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,627.63 |
| Consulting Fee | $1,662.50 |
| Education | $84.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $10,599.48 | 2019 | |
| Novo Nordisk INC | $6,324.29 | 2019-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $4,966.13 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Janssen Pharmaceuticals, INC | $2,966.95 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $2,719.46 | 2019-2025 | Entresto, Leqvio |
| Amgen INC. | $1,743.61 | 2019-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $1,650.97 | 2019 | |
| Abbott Laboratories | $1,372.08 | 2019-2025 | Mitraclip, Aveir, Triclip |
| E.R. Squibb & Sons, L.L.C. | $1,164.46 | 2019-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $1,153.73 | 2021-2025 | Onyx Frontier, Symplicity G3, Micra |
| Merck Sharp & Dohme LLC | $1,104.83 | 2019-2025 | Verquvo, Winrevair, Capvaxive |
| Actelion Pharmaceuticals US, INC. | $1,009.63 | 2020-2025 | Uptravi, Opsumit, Opsynvi |
| Boston Scientific Corporation | $1,002.95 | 2019-2025 | Ilab Ultrasound Imaging System, General - Vascular Intervention, Avvigo Guidance System |
| Esperion Therapeutics, INC. | $830.79 | 2020-2024 | Nexletol, Nexlizet |
| Amarin Pharma, INC. | $718.78 | 2019-2023 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $632.00 | 2019-2025 | Jardiance |
| Shockwave Medical, INC | $564.37 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Sanofi-Aventis U.S. LLC | $414.89 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $403.95 | 2019-2025 | Lifevest |
| Lilly USA, LLC | $352.48 | 2019-2024 | Mounjaro |
| Cvrx, INC. | $347.26 | 2023-2024 | Barostim Neo System |
| Edwards Lifesciences Corporation | $344.80 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Pfizer INC. | $338.40 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $288.70 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $287.90 | 2019-2023 | Livalo, Seglentis |
| Arbor Pharmaceuticals, INC. | $262.46 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $226.46 | 2023-2024 | Inpefa |
| Abbvie INC. | $206.48 | 2022-2023 | |
| Biotronik INC. | $195.31 | 2022 | |
| Irhythm Technologies, INC. | $184.39 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Abiomed | $183.68 | 2024-2025 | Impella |
| Medicure Pharma INC. | $163.83 | 2020-2024 | Zypitamag |
| Scpharmaceuticals INC. | $112.97 | 2024-2025 | |
| Atricure, INC. | $111.04 | 2023 | |
| Agepha Pharma Fz LLC | $109.90 | 2024-2025 | Lodoco |
| Vifor Pharma, INC. | $107.45 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $97.08 | 2020-2023 | Contrave |
| Tactile Systems Technology INC | $85.92 | 2020-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Chiesi USA, INC. | $75.55 | 2019 | |
| Digirad Health, INC | $45.10 | 2025 | Cardius |
| Idorsia Pharmaceuticals US INC | $41.54 | 2023-2024 | Quviviq |
| Lundbeck LLC | $39.88 | 2019-2020 | |
| Genzyme Corporation | $35.56 | 2020-2021 | |
| Inspire Medical Systems, INC. | $31.92 | 2025 | Inspire |
| Kiniksa Pharmaceuticals, LTD. | $30.01 | 2023 | Arcalyst |
| Glaxosmithkline, LLC. | $21.03 | 2025 | Shingrix, Arexvy |
| Azurity Pharmaceuticals, INC. | $19.78 | 2023 | Horizant |
| Teleflex LLC | $18.65 | 2025 | Manta |
| Amryt Pharma Holdings LTD | $18.08 | 2022 | |
| Preventice Services, LLC | $17.56 | 2021 | |
| Gilead Sciences, INC. | $17.24 | 2019 | |
| Bardy Diagnostics, INC. | $12.68 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gloria Hui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.